Medibank IPO: prognosis negative

This medical insurer isn't the safe stock it's made out to be and it needs more than a 4% dividend yield to attract us.

Medibank chief executive George Savvides tells a story of a tense wage negotiation with unions at the Australian arm of UK medical products company Smith & Nephew, which he was running in the 1990s. As the negotiations heated up, a shop steward told him that the issue was not so much the 4% wage claim, but the concern of low-paid workers that their families would be left unprotected if they fell ill or died.

{{content.question}}

{{ twilioFailed ? 'SMS Code Failed to Send…' : 'SMS Code Sent…' }}

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

We cannot send you a code via SMS to {{user.DayPhone}}

If you didn't receive SMS code please

SMS code cannot be sent due to: {{ twilioStatus }}

Please select one of the options below:

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa
Mastercard

The email address you entered is registered with InvestSMART.

Please login or select "Don't know password"

Please untick this box when using a public or shared device


Register as a new member

(using a different email)

Related Articles